Resmed (RMD) Net Cash Flow Growth (1y) (2010 - 2026)
Resmed (RMD) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.12 Bn | 120.90 Bn | 1.96 Bn | -9.88% |
| 2 | Becton Dickinson | 44.89 Bn | 44.07 Bn | 2.15 Bn | 131.47% |
| 3 | Alcon | 33.06 Bn | 31.40 Bn | 1.53 Bn | - |
| 4 | Medline | 32.81 Bn | 30.58 Bn | 1.84 Bn | -47.85% |
| 5 | Resmed | 29.44 Bn | 27.78 Bn | 890.98 Mn | -40.20% |
| 6 | West Pharmaceutical Services | 23.12 Bn | 22.68 Bn | 329.20 Mn | -196.55% |
| 7 | Solventum | 14.06 Bn | 13.50 Bn | 1.10 Bn | -41.07% |
| 8 | Cooper Companies | 13.87 Bn | 13.73 Bn | 735.40 Mn | 102.38% |
| 9 | Align Technology | 12.07 Bn | 11.01 Bn | 736.59 Mn | 84.02% |
| 10 | Baxter International | 11.93 Bn | 9.91 Bn | 891.00 Mn | 215.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.20% |
| Dec 31, 2025 | -75.52% |
| Sep 30, 2025 | -1.39% |
| Jun 30, 2025 | 74,796.27% |
| Mar 31, 2025 | 1,121.91% |
| Dec 31, 2024 | 1,811.28% |
| Sep 30, 2024 | 1,379.39% |
| Jun 30, 2024 | -86.13% |
| Mar 31, 2024 | 231.36% |
| Dec 31, 2023 | -120.69% |
| Sep 30, 2023 | 75.32% |
| Jun 30, 2023 | -97.16% |
| Mar 31, 2023 | -454.16% |
| Dec 31, 2022 | 143.15% |
| Sep 30, 2022 | -284.75% |
| Jun 30, 2022 | 26.90% |
| Mar 31, 2022 | 133.94% |
| Dec 31, 2021 | 53.89% |
| Sep 30, 2021 | 72.72% |
| Jun 30, 2021 | -28.81% |